Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?
Sarah E. Packer
,
Patrick M. Brunner
Icahn School of Medicine at Mount Sinai
Waldman Department of Dermatology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cutaneous T Cell Lymphoma
100%
Janus Kinase Inhibitor
100%
Prevalence
20%
Inflammatory Disorder
20%
Controlled Clinical Trial
20%
JAK-STAT Signaling
20%
Medical Device
20%
Mycosis fungoides
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Janus Kinase Inhibitor
100%
Cutaneous T Cell Lymphoma
100%
Prevalence
20%
Inflammatory Disease
20%
Controlled Clinical Trial
20%
Mycosis fungoides
20%
Diseases
20%
JAK-STAT Signaling
20%
Keyphrases
Skin-directed Treatment
20%